InflaRx (IFRX) Retained Earnings (2016 - 2026)

InflaRx's (IFRX) quarterly Retained Earnings came in at $58.0 million in Q1 2026, up 18.24% year-on-year from $49.0 million in Q1 2025, and up 2.52% quarter-over-quarter from $56.5 million in Q4 2025.

InflaRx (IFRX) Retained Earnings (2016 - 2026) Analysis & Trends

InflaRx has disclosed Retained Earnings across 11 years of filings, most recently posting $58.0 million for Q1 2026.

  • Retained Earnings for Q1 2026 came in at $58.0 million, up 18.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.0 million (up 18.24% YoY), and the FY2025 annual result was $56.5 million, up 115.92% from the prior year.
  • Retained Earnings came in at $58.0 million for Q1 2026 at InflaRx, up from $56.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $58.0 million in Q1 2026 to a low of -$355.0 million in Q4 2024.
  • The 5-year median for Retained Earnings is $43.1 million (2023), against an average of $22.2 million.
  • Across the five-year window, Retained Earnings sank 923.78% in 2024 and soared 115.92% in 2025, its largest moves.
  • InflaRx's Retained Earnings stood at $37.4 million in 2022, then increased by 15.29% to $43.1 million in 2023, then tumbled by 923.78% to -$355.0 million in 2024, then jumped by 115.92% to $56.5 million in 2025, then gained by 2.52% to $58.0 million in 2026.
  • The last three Retained Earnings figures came in at $58.0 million (Q1 2026), $56.5 million (Q4 2025), and $56.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -153.89 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -211.85 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -279.00 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 130.89 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -1.88
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 14.59 Bn
9 Abivax 94.26 Bn 94.26 Bn - -838.07 Mn
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 57.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 57.95 Mn
Dec 31, 2025 56.53 Mn
Sep 30, 2025 56.47 Mn
Jun 30, 2025 54.00 Mn
Mar 31, 2025 49.01 Mn
Dec 31, 2024 -354.98 Mn
Sep 30, 2024 48.08 Mn
Jun 30, 2024 46.44 Mn
Mar 31, 2024 45.53 Mn
Dec 31, 2023 43.09 Mn
Sep 30, 2023 43.10 Mn
Jun 30, 2023 42.33 Mn
Mar 31, 2023 40.62 Mn
Dec 31, 2022 37.38 Mn
Sep 30, 2022 36.47 Mn
Jun 30, 2022 37.62 Mn
Mar 31, 2022 37.17 Mn
Dec 31, 2021 35.00 Mn
Sep 30, 2021 35.48 Mn
Jun 30, 2021 34.86 Mn